Friday , January 27 2023

Doctors say patients demand medical use of marijuana


Patients with different diagnoses do not proceed with traditional treatment, they are more interested in medical use of marijuana. For this second edition of the International Seminary "Medicinal Canabis, A Look for the Future" this hypothesis has been divided in Rio de Janeiro this weekend.

Marijuana plant (advertising)

According to him, growing demand is influenced by scientific development, media coverage and the possibility of leaving the crop for medicinal purposes, subject to public disclosure by the National Sanitary Surveillance Agency (Añivisa). "There is no doubt that demand will increase." Neurologist Eduardo Favrett, director of the Center for Epilepsy Center of Brain Paula Niemer State Institute of Epilepsy, a unit associated with the Rio de Janeiro government, said that we need to be ready to attend.

This conclusion is divided by Orthopedic Ricardo Ferreira, who has long been an expert in medical and surgical treatment of pain and spinal cord Pathology. "Patients have sought to improve their lifestyle and seek the advice of doctors. I have received more and more patients who have already documented the history of pain in traditional methods, which were done without other successes by other doctors.

Ricardo said that while he was looking for alternatives in cases where the available remedies in the market were ineffective, they were interested in the medical use of marijuana. "I have seen that there is increasing evidence of the possibility of using cannabis for the treatment of long-suffering. In some countries like the Netherlands and Canada and in some states of the United States, they were already studied with that conclusion."

Since 2015, Envisa has authorized cannabis medical prescriptions. There is a problem getting the product. After banning commercialization in Brazil, drugs need to be imported. In possession of a medical prescription, the patient must sign the duration of the liability and wait for the authenticity of Aniwasas. Import, veto by companies for distribution in Brazil. Authentication for each patient is approved individually.

The exception is the mavetail, also known as sewettes, which was approved by Envira and came to the country's pharmacy last year. It has been suggested, for example, for some patients with multiple sclerosis, a disease that causes melanism inflammation and destruction, protective levels of the nerve cells.

According to Fiorez, more than 8,000 patients in Brazil are now authorized to import cannabis for various types of diseases. After 2015, the orthopedist suggests these drugs for more than 300 people.

"150 people had complied with the procedures for obtaining import authorization and were able to achieve production effectively, and half of the pain received substantial relief and continued to be used. Today I am about 120 questions per week, of them 10, in average I suggest cannabis. I continue the surgery, I continue to suggest conventional remedies. Entrances to neurological arsenal, especially in cases that do not respond to conventional remedies. "


The International Seminar "Medical cannabis, Future for Future", which takes place at the European Institute of Design (IED) tomorrow (30), is a result of the partnership between research support and medicinal cannabis patients. ) And Oswaldo Cruz Foundation (Fiocruz), a scientific organization associated with the Ministry of Health. The initiative is also supported by the Brazilian Society for the Advancement of Science (SBPC).

In addition to Brazilian doctors and researchers, experts from Chile, Spain, Argentina, Colombia, Peru and Panama are meeting in the event. They discuss the evidence of benefits for patients with cancer, brain, chronic pain, Alzheimer's, and multiple sclerosis. Substances such as canabidiol and tetrahedrokrokanabinol (THC) have already recognized the effects of antioxidant, antidepressant and anti-inflammatory effects.

"These are two of the most clinically studied objects, but others are also the therapeutic arsenal of cannabides and terepens, and plants grow from this plant, which has cannabis rich in canbiodole, others are in THC. The plant genetically interferes with the type of oil Which they will offer. In Brazil, people born here are generally rich in THC. THC has some therapeutic applications, but your Will focus on the dose control, follow-up the issue of age, "warned favorite.

It progresses in neurology and oncology. "Phase 2 clinical research has improved a very good improvement for patients with giloblastoma multiforme, which is the biggest type of brain. Canabas has survived average, quality of life improved," he said. Also notes neurotransmitter research that focuses on better radiotherapy results when associated with the use of marijuana in treatments.

Substances can serve on the basis of ointment, tea, oil, butter. There are also the effects of smoking cure, but doctors say that the effect is short. The nature of usage should be defined in prescription, some factors such as treatment problems, patient age and physical condition


Patients and families and families diagnosed with various types also participate in the seminar. "They are welcome in scientific events, form associations, other patients and their families. This is a process that involves many citizenship and has a lot of awareness," said the chief.

Since 2013, cannabis improves the quality of his daughter's brain, the lawyer Margaret Brito is one of the main mobilizations of civil society in Rio de Janeiro around this topic. The Appointment coordinator, who organizes the seminar together with the Fiocross, has already won international awards and documented its history "Illegal – Life Not Waiting".

"Today people are funded by default, which is high in costs, patients spend at least R $ 1,500 per month. In addition to being expensive, it is time consuming and bureaucracy to enable this importation of therapeutic. In any case, it is very complicated. That's the reason we are in this fight, "he explained.

She believes that realization can improve the reality by regulating agriculture for medicinal purposes. Some patients get the court's approval to leave individually. In 2017, the Brazilian Association of Support Canabis Aspenaca (Abrasas), an entity located in Peso, received the right to make oil from marijuana to treat associated patients. Today, the only country in the country that is authorized for collective farming. Two weeks ago, the APPA filed an action seeking the same right from Auberge.

At the same time, the public consultation on this topic is open until August 19 and any citizen or organization can give his opinion. "We hope that this regulation will cater to the actual demand of patients, not only in the production of commercial but also in the form of collective farming, so that organizations can produce plants and their extracts in the standard of both good practices of agriculture and pharmacological," said Orthopedic Ricardo Ferreira. Was.

(*) With information from Agniesia Brasil

Source link